Eisai and Biogen’s Leqembi is the first drug to show that reducing a protein linked to Alzheimer’s helped patients

This post first appeared on wsj.com

You May Also Like

Toshiba’s New Breakup Plan Faces Lower Shareholder Hurdle

TOKYO— Toshiba Corp.’s TOSYY 0.92% revised plan to break into two parts…

U.S. pushes for more U.N. aid corridors to Syria in wake of devastating earthquakes

The U.S is pushing for more safe passages for U.N. humanitarian aid…

Baidu’s ChatGPT Rival Ernie Bot Didn’t Go Live at Its Launch Party

Tech The chatbot is aimed at reviving the Chinese tech firm’s fortunes…

A professional dancer reunites with his mom after a more than 20-year separation

Daniel Zapata Colón had not seen his mother since he was a…